Checkpoint inhibitor monotherapy in potentially studyeligible or non-study-eligible NSCLC patients in the German CRISP Registry real-world cohort (AIO-TRK-0315). 3. Dezember 2022 F Griesinger; M Sebastian; W Brückl; H-D Hummel; B Jaeschke; J Kern; C Wesseler; M Jänicke; A Fleitz; S Zacharias; A Hipper; A Groth; W Weichert; S Dörfel; V Petersen; J Schröder; J Wilke; W E E Eberhardt; M Thomas, 2022. Oncol Res Treat 2022;45(suppl 1):151 Download RAS mutant metastatic colorectal cancer – Real-world data from more than 1000 patients from the Clinical Tumor Registry Colorectal Cancer (TKK). Dörfel S, Bernhardt C, Eggers E, Fruehauf S, Maintz C, Behringer J, u. a. Oncol Res Treat. 2022;45(suppl 1)(245):64. Download… Weiterlesen Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry. Metzenmacher M, Griesinger F, Hummel HD, Elender C, Schäfer H, de Wit M, Kaiser U, Kern J, Jänicke M, Spring L, Zacharias S, Kaiser-Osterhues A,… Weiterlesen